LAS Cruces Dialysis (FMC) is a medicare approved dialysis facility center in Las Cruces, New Mexico and it has 25 dialysis stations. It is located in Dona Ana county at 3875 Foothills Rd, Las Cruces, NM, 88011. You can reach out to the office of LAS Cruces Dialysis (FMC) at (575) 522-5858. This dialysis clinic is managed and/or owned by Fresenius Medical Care. LAS Cruces Dialysis (FMC) has the following ownership type - Profit. It was first certified by medicare in December, 1981. The medicare id for this facility is 322505 and it accepts patients under medicare ESRD program.
| Name | LAS Cruces Dialysis (FMC) |
|---|---|
| Location | 3875 Foothills Rd, Las Cruces, New Mexico |
| No. of Dialysis Stations | 25 |
| Medicare ID | 322505 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 3875 Foothills Rd, Las Cruces, New Mexico, 88011 | |
| (575) 522-5858 | |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| NPI Number | 1447362348 |
| Organization Name | Fresenius Medical Care Las Cruces |
| Doing Business As | Renal Care Group South New Mexico, Llc |
| Address | 3875 Foothills Rd Las Cruces, New Mexico, 88011 |
| Phone Number | (505) 522-5858 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 62% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 18% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 56% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 14% |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 51% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 19% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 30% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 52% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 12% |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 76% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 24% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 26% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 12% |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 56 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 16 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 137 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1139 |
| Percentage of adult patients getting regular hemodialysis at the center | 93 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 28 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 213 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 90 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at LAS Cruces Dialysis (FMC) with elevated calcium levels.
| Patients with hypercalcemia | 168 |
| Hypercalcemia patient months | 1459 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 176 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 26 |
| Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 114 |
| Patient months included in arterial venous fistula and catheter summaries | 844 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 78 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 127 |
| Hospitalization Rate in facility | 211.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 327.3 |
| Hospitalization Rate: Lower Confidence Limit | 145.6 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at LAS Cruces Dialysis (FMC) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 28.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 40.8 |
| Readmission Rate: Lower Confidence Limit | 18.8 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at LAS Cruces Dialysis (FMC) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.27 (As Expected) |
| SIR: Upper Confidence Limit | 2.27 |
| SIR: Lower Confidence Limit | .65 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether LAS Cruces Dialysis (FMC)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 112 |
| Transfusion Rate in facility | 42.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 83.5 |
| Transfusion Rate: Lower Confidence Limit | 23.9 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at LAS Cruces Dialysis (FMC) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 599 |
| Mortality Rate in facility | 25.8 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 32.1 |
| Mortality Rate: Lower Confidence Limit | 20.5 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago
LAS Cruces Dialysis (FMC) Location: 3875 Foothills Rd, Las Cruces, New Mexico, 88011 Phone: (575) 522-5858 |
LAS Cruces Renal Center (DVA) Location: 3961 E Lohman Ave Ste 29, Las Cruces, New Mexico, 88011 Phone: (575) 532-9437 |
LAS Cruces South Dialysis (FMC) Location: 2525 S Telshor Blvd Ste B, Las Cruces, New Mexico, 88011 Phone: (575) 532-6066 |
Mesilla Valley Dialysis (DVA) Location: 2550 S Telshor Blvd, Las Cruces, New Mexico, 88011 Phone: (575) 522-3519 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Researchers in Australia have reported that pregnant women in Melbourne were more likely to have a preterm stillbirth during the period when coronavirus disease 2019 (COVID-19) lockdown restrictions were imposed on the city, than they were during the corresponding period one and two years prior.
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
The American Heart Association has awarded Loyola University Chicago Stritch School of Medicine $438,740 for cardiac research in 2013, bringing the lifetime total the organization has awarded to Loyola to $10.6 million.
› Verified 2 days ago